(NASDAQ: GOVX) Geovax Labs's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.32%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.27%.
Geovax Labs's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast GOVX's revenue for 2026 to be $289,998,312, with the lowest GOVX revenue forecast at $289,998,312, and the highest GOVX revenue forecast at $289,998,312. On average, 1 Wall Street analysts forecast GOVX's revenue for 2027 to be $58,368,949, with the lowest GOVX revenue forecast at $58,368,949, and the highest GOVX revenue forecast at $58,368,949.
In 2028, GOVX is forecast to generate $138,656,122 in revenue, with the lowest revenue forecast at $138,656,122 and the highest revenue forecast at $138,656,122.